The Discounted Cash Flow (DCF) valuation of Angion Biomedica Corp (ANGN) is (33.90) USD. With the latest stock price at 1.00 USD, the upside of Angion Biomedica Corp based on DCF is -3490.0%.
Based on the latest price of 1.00 USD and our DCF valuation, Angion Biomedica Corp (ANGN) is a sell. selling ANGN stocks now will result in a potential gain of 3490.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.9% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (109.17) - (20.55) | (33.90) |
| Upside | -11016.9% - -2154.8% | -3490.0% |